Latest Breaking News On - India astrazeneca - Page 7 : comparemela.com

Expert panel to meet on January 1 to review data on Serum Institute, Bharat Biotech COVID-19 vaccines The SEC, which met on December 30, couldn t take a decision on SII s COVID-19 vaccine, as it needed more data. Source: Reuters The Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO), India s drug regulator, will be meeting on January 1 to further review the emergency use applications of Serum Institute of India (SII) and Bharat Biotech COVID-19 vaccines. The SEC which met on December 30 couldn t take a decision on SII s COVID-19 vaccine, as it needed more data. The additional data and information presented by SII and Bharat Biotech was perused and analysed by the SEC. The analysis of the additional data and information is going on. SEC will convene again on 1 January 2021 (Friday), the CDSCO said in a statement.

United kingdomWorld health organizationCentral drugs standard control organisationSerum institute of indiaOxford universityExpert committeeSubject expert committeeSerum instituteBharat biotechOxford university astrazenecaIndia astrazenecaஒன்றுபட்டது கிஂக்டம்உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந்மைய மருந்துகள் தரநிலை கட்டுப்பாடு ஆர்கநைஸேஶந்சீரம் நிறுவனம் ஆஃப் இந்தியாஆக்ஸ்ஃபர்ட் பல்கலைக்கழகம்